Healthcare / Healthcare PlansNYSE
$402.66
+9.47 (+2.41%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 22% · confianza 25%
FCF escenarios
weak_data · normalized FCF $4.6B · quality 66.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
46/100
C
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$87.4B
P/E
17.1x
↓EV/EBITDA
N/A
•ROE
12.9%
↑Gross Margin
N/A
•Debt/Equity
0.73
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2007–2025 · 18 años de histórico normalizado
Revenue CAGR
+6.8%
FCF CAGR
-1.3%
FCF margin
1.6%
FCF / Net income
0.56x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $199.13B · net income $5.66B · FCF $3.17B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||||||||||
| Revenue | $199.13B | $199.13B | $176.81B | $171.34B | $156.59B | $138.64B | $121.87B | $104.21B | $92.11B | $90.04B | $84.86B | $79.16B | $73.87B | $71.02B | $61.50B | $60.71B | $58.70B | $64.94B | $61.25B | $61.17B |
| Net Income | $5.66B | $5.66B | $5.98B | $5.99B | $5.89B | $6.16B | $4.57B | $4.81B | $3.75B | $3.84B | $2.47B | $2.56B | $2.57B | $2.49B | $2.66B | $2.65B | $2.89B | $4.75B | $2.49B | $3.35B |
| EBITDA | — | — | — | — | — | $8.86B | $7.51B | $7.13B | $6.56B | — | — | — | — | — | — | — | — | — | — | — |
| EPS | 25.21 | 25.21 | 25.68 | 25.22 | 24.81 | 24.95 | 17.98 | 18.47 | 14.19 | 14.35 | 9.21 | 9.38 | 8.99 | 8.20 | 8.18 | 7.25 | 6.94 | 9.88 | 4.76 | 5.56 |
| Operating Margin | — | — | — | — | — | 5.5% | 5.2% | 5.8% | 5.9% | 4.6% | 5.7% | 6.0% | 6.0% | 5.6% | 5.9% | 6.2% | 6.9% | 6.4% | 7.1% | — |
| Net Margin | 2.8% | 2.8% | 3.4% | 3.5% | 3.8% | 4.4% | 3.8% | 4.6% | 4.1% | 4.3% | 2.9% | 3.2% | 3.5% | 3.5% | 4.3% | 4.4% | 4.9% | 7.3% | 4.1% | 5.5% |
| Balance Sheet | ||||||||||||||||||||
| Debt/Equity | 0.73 | 0.73 | 0.76 | 0.64 | 0.67 | 0.59 | 0.58 | 0.56 | 0.60 | 0.66 | 0.57 | 0.66 | 0.58 | 0.55 | 0.60 | 0.36 | 0.34 | 0.34 | 0.37 | — |
| Current Ratio | 1.48 | 1.48 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Cash Flow | ||||||||||||||||||||
| Free Cash Flow | $3.17B | $3.17B | $4.55B | $6.76B | $7.25B | $7.28B | $9.67B | $4.98B | $2.62B | $3.39B | $2.69B | $3.57B | $2.65B | $2.41B | $2.20B | $2.85B | $965.3M | $2.66B | $2.19B | $4.02B |
| Returns | ||||||||||||||||||||
| ROE | 12.9% | 12.9% | 14.5% | 15.2% | 16.3% | 17.1% | 13.8% | 15.2% | 13.1% | 14.5% | 9.8% | 11.1% | 10.6% | 10.1% | 11.2% | 11.4% | 12.1% | 19.1% | 11.6% | 14.6% |
| Valuation | ||||||||||||||||||||
| P/E | 17.07 | 17.07 | 14.47 | 19.03 | 19.16 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| P/B | 2.06 | 2.06 | 2.09 | 2.90 | 3.19 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Growth & Yield | ||||||||||||||||||||
| Revenue Growth | 12.6% | 12.6% | 3.2% | 9.4% | — | 13.8% | 16.9% | 13.1% | 2.3% | 6.1% | 7.2% | 7.2% | 4.0% | 15.5% | 1.3% | 3.4% | -9.6% | 6.0% | 0.1% | — |
| EPS Growth | -1.8% | -1.8% | 1.8% | 1.7% | — | 38.8% | -2.7% | 30.2% | -1.1% | 55.8% | -1.8% | 4.3% | 9.6% | 0.2% | 12.8% | 4.5% | -29.8% | 107.6% | -14.4% | — |
| Dividend Yield | 1.7% | 1.7% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
12.3%
EPS terminal req.
$35.73
Spread vs growth
-14.2%
5Y implied EPS CAGR
11.4%
EPS terminal req.
$43.23
Spread vs growth
-13.2%
10Y implied EPS CAGR
10.7%
EPS terminal req.
$69.63
Spread vs growth
-12.5%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+6.6%
Start / end P/E
14.9x → 16.0x
EPS bridge
25.68 → 25.21
Residual
-0.1%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.